EZI Biolab: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EZI Biolab
Largest movements
- Tangible fixed assets -€35,294
down €35,294 (-7.2%), from €488,756 to €453,462
- Receivables within one year -€30,059
down €30,059 (-56.6%), from €53,146 to €23,086
- Stocks and contracts +€22,610
up €22,610 (+50.6%), from €44,689 to €67,299
- Debts after one year -€32,771
down €32,771 (-9.7%), from €336,754 to €303,983
- Profit (loss) carried forward -€20,694
down €20,694 (-16.3%), from €126,906 to €106,212
- Gross operating margin -€18,076
down €18,076 (-18.5%), from €97,922 to €79,847
- Other operating charges -€2,348
down €2,348 (-59.7%), from €3,933 to €1,585
- Staff costs +€1,999
up €1,999 (+4.3%), from €46,674 to €48,673
- Depreciation -€1,390
down €1,390 (-3.3%), from €41,820 to €40,430
- Financial charges -€1,170
down €1,170 (-10.9%), from €10,690 to €9,520
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €648,470 | €599,741 | -€48,728 | -7.5% |
| Fixed assets | 21/28 | €489,841 | €454,367 | -€35,474 | -7.2% |
| Intangible fixed assets | 21 | €435 | €255 | -€180 | -41.3% |
| Tangible fixed assets | 22/27 | €488,756 | €453,462 | -€35,294 | -7.2% |
| Land and buildings | 22 | €417,589 | €400,359 | -€17,231 | -4.1% |
| Plant, machinery and equipment | 23 | €14,134 | €10,256 | -€3,879 | -27.4% |
| Furniture and vehicles | 24 | €57,032 | €42,847 | -€14,185 | -24.9% |
| Financial fixed assets | 28 | €650 | €650 | = | 0.0% |
| Current assets | 29/58 | €158,629 | €145,374 | -€13,255 | -8.4% |
| Stocks and contracts in progress | 3 | €44,689 | €67,299 | +€22,610 | +50.6% |
| Stocks | 30/36 | €44,689 | €67,299 | +€22,610 | +50.6% |
| Amounts receivable within one year | 40/41 | €53,146 | €23,086 | -€30,059 | -56.6% |
| Trade receivables | 40 | €53,146 | €23,086 | -€30,059 | -56.6% |
| Cash at bank and in hand | 54/58 | €57,002 | €51,906 | -€5,095 | -8.9% |
| Deferred charges and accrued income | 490/1 | €3,793 | €3,083 | -€710 | -18.7% |
| Total equity and liabilities | 10/49 | €648,470 | €599,741 | -€48,728 | -7.5% |
| Equity | 10/15 | €173,149 | €152,455 | -€20,694 | -12.0% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €21,243 | €21,243 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,500 | €2,500 | = | 0.0% |
| Reserves not available under the articles | 1311 | €2,500 | €2,500 | = | 0.0% |
| Tax-exempt reserves | 132 | €18,743 | €18,743 | = | 0.0% |
| Profit (loss) carried forward | 14 | €126,906 | €106,212 | -€20,694 | -16.3% |
| Amounts payable | 17/49 | €475,321 | €447,287 | -€28,034 | -5.9% |
| Amounts payable after more than one year | 17 | €336,754 | €303,983 | -€32,771 | -9.7% |
| Financial debts | 170/4 | €336,754 | €303,983 | -€32,771 | -9.7% |
| Amounts payable within one year | 42/48 | €138,566 | €143,303 | +€4,737 | +3.4% |
| Current portion of amounts payable after more than one year | 42 | €30,786 | €33,869 | +€3,083 | +10.0% |
| Trade debts | 44 | €9,831 | €11,360 | +€1,529 | +15.6% |
| Suppliers | 440/4 | €9,831 | €11,360 | +€1,529 | +15.6% |
| Taxes, remuneration and social security | 45 | €29,363 | €29,085 | -€278 | -0.9% |
| Taxes | 450/3 | €17,299 | €15,753 | -€1,545 | -8.9% |
| Remuneration and social security | 454/9 | €12,065 | €13,332 | +€1,267 | +10.5% |
| Other amounts payable | 47/48 | €68,586 | €68,990 | +€404 | +0.6% |
| Remuneration, social security and pensions | 62 | €46,674 | €48,673 | +€1,999 | +4.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,820 | €40,430 | -€1,390 | -3.3% |
| Other operating charges | 640/8 | €3,933 | €1,585 | -€2,348 | -59.7% |
| Gross operating margin | 9900 | €97,922 | €79,847 | -€18,076 | -18.5% |
| Operating profit (loss) | 9901 | €5,496 | -€10,842 | -€16,337 | |
| Financial income | 75/76B | €890 | €340 | -€550 | -61.8% |
| Recurring financial income | 75 | €890 | €340 | -€550 | -61.8% |
| Financial charges | 65/66B | €10,690 | €9,520 | -€1,170 | -10.9% |
| Recurring financial charges | 65 | €10,690 | €9,520 | -€1,170 | -10.9% |
| Profit (loss) for the period before taxes | 9903 | -€4,304 | -€20,021 | -€15,717 | -365% |
| Income taxes | 67/77 | €1,313 | €673 | -€640 | -48.7% |
| Profit (loss) for the period | 9904 | -€5,617 | -€20,694 | -€15,077 | -268% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,617 | -€20,694 | -€15,077 | -268% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.